The 56 rating InvestorsObserver gives to Oncolytics Biotech, Inc. (ONCY) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 64 percent of stocks in the Biotechnology industry, ONCYs 56 overall rating means the stock scores better than 56 percent of all stocks.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Oncolytics Biotech, Inc. (ONCY) stock is up 1.91% while the S&P 500 is lower by -0.6% as of 3:00 PM on Wednesday, Oct 14. ONCY is higher by $0.04 from the previous closing price of $2.08 on volume of 475,049 shares. Over the past year the S&P 500 is higher by 16.53% while ONCY is higher by 341.67%. ONCY lost -$0.78 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Oncolytics Biotech, Inc. (ONCY) Stock.

Read the original:
Where Does Oncolytics Biotech, Inc. (ONCY) Stock Fall in the Biotechnology Field? - InvestorsObserver